{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:18:38Z","timestamp":1778206718708,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"International Clinical, Operational and Health Services Research Training Award for AIDS and Tuberculosis","award":["5 U2R TW006883-02"],"award-info":[{"award-number":["5 U2R TW006883-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cmi.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T13:47:07Z","timestamp":1511444827000},"page":"889-895","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in S\u00e3o Paulo, Brazil: a cross-sectional study"],"prefix":"10.1016","volume":"24","author":[{"given":"J.F.","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.W.","family":"Pinhata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M.N.","family":"Galesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferrazoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.11.015_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2017.11.015_bib2","series-title":"Global tuberculosis report, 2016","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.cmi.2017.11.015_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2017.11.015_bib4","first-page":"1","article-title":"Indicadores priorit\u00e1rios para o monitoramento do Plano Nacional pelo Fim da Tuberculose como Problema de Sa\u00fade P\u00fablica no Brasil","volume":"48","author":"da Sa\u00fade","year":"2017","journal-title":"Bol Epidemiol"},{"key":"10.1016\/j.cmi.2017.11.015_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diagmicrobio.2016.10.023","article-title":"Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960","volume":"87","author":"Adami","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib6","series-title":"Policy guidance on drug-susceptibility testing (DST) of second-line antituberculous drugs","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.cmi.2017.11.015_bib7","first-page":"1449","article-title":"Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the BACTEC MGIT 960 system","volume":"12","author":"Rodrigues","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.mimet.2017.06.007","article-title":"Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs","volume":"139","author":"Gallo","year":"2017","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1016\/j.cmi.2017.11.015_bib9","first-page":"803","article-title":"Differentiation of Mycobacterium tuberculosis from other mycobacteria with nitrobenzoic acid using MGIT960","volume":"11","author":"Giampaglia","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib10","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JCM.29.11.2578-2586.1991","article-title":"Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence\u2013dependent DNA polymorphism as a tool in the epidemiology of tuberculosis","volume":"29","author":"Van Soolingen","year":"1991","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.11.015_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/JCM.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology","volume":"31","author":"Van Embden","year":"1993","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2017.11.015_bib12","first-page":"18","article-title":"Transmission of tuberculosis in an endemic urban setting in Brazil","volume":"4","author":"Ferrazoli","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(13)70030-6","article-title":"Drug-resistant tuberculosis: time for visionary political leadership","volume":"13","author":"Abubakar","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib14","series-title":"Manual de Recomenda\u00e7\u00f5es para o Controle da Tuberculose no Brasil","author":"da Sa\u00fade","year":"2011"},{"key":"10.1016\/j.cmi.2017.11.015_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5365\/wpsar.2016.7.2.002","article-title":"Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011","volume":"7","author":"Nguyen","year":"2016","journal-title":"Western Pac Surveill Response J"},{"issue":"46","key":"10.1016\/j.cmi.2017.11.015_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/524017","article-title":"Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital","volume":"1","author":"Jeon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib17","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study","volume":"380","author":"Dalton","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2017.11.015_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CLEP.S35839","article-title":"Extensively drug-resistant tuberculosis: epidemiology and management","volume":"6","author":"Matteelli","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cmi.2017.11.015_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.healthpol.2003.07.010","article-title":"Equality or equity in health care access: a qualitative study of doctors\u2019 explanations to a longer doctor\u2019s delay among female TB patients in Vietnam","volume":"68","author":"Thorson","year":"2004","journal-title":"Health Policy"},{"key":"10.1016\/j.cmi.2017.11.015_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1590\/S0102-311X2007000300015","article-title":"Why do men use health services less than women? Explanations by men with low versus higher education","volume":"23","author":"Gomes","year":"2007","journal-title":"Cad Saude Publica"},{"issue":"1","key":"10.1016\/j.cmi.2017.11.015_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0102-37722009000100007","article-title":"Concep\u00e7\u00f5es de Homens Hospitalizados sobre a Rela\u00e7\u00e3o entre G\u00eanero e Sa\u00fade","volume":"25","author":"Costa-J\u00fanior","year":"2009","journal-title":"Psic Teor Pesq"},{"key":"10.1016\/j.cmi.2017.11.015_bib22","first-page":"89","article-title":"Fatores de risco para tuberculose multirresistente adquirida","volume":"29","author":"Barroso","year":"2003","journal-title":"J\u00a0Pneumol"},{"key":"10.1016\/j.cmi.2017.11.015_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055299","article-title":"Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region","volume":"8","author":"Porwal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.11.015_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2017.11.015_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"Jacobson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.015_bib26","first-page":"52","article-title":"Mycobacterium tuberculosis resistente: de onde vem a resist\u00eancia?","volume":"7","author":"Campos","year":"1999","journal-title":"Bol Pneumol Sanit"},{"key":"10.1016\/j.cmi.2017.11.015_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modeling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:22:17Z","timestamp":1603387337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17306468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1198743X17306468"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.11.015","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}